Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c199
Identifier NCT03422861
Trial Title Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: Nabilone|DRUG: Placebos
Participant Information
Sponsor Samuel Lunenfeld Research Institute, Mount Sinai Hospital
City Toronto
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2025-12-23
Primary Completion Date 2025-09-24
Completion Date 2025-12-24